ERBB2 and breast carcinoma: For instance, the PAM50 gene signature measures the expression levels of 50 genes in breast cancer samples to classify a tumor as one of five intrinsic subtypes (luminal A, luminal B, HER2-enriched, basal-like and normal like), and it has prognostic value in both untreated and tamoxifen treated patient populations [7, 8].